medigraphic.com
SPANISH

Ginecología y Obstetricia de México

Federación Mexicana de Ginecología y Obstetricia, A.C.
  • Contents
  • View Archive
  • Information
    • General Information        
    • Directory
  • Publish
    • Instructions for authors        
  • medigraphic.com
    • Home
    • Journals index            
    • Register / Login
  • Mi perfil

2020, Number 06

<< Back Next >>

Ginecol Obstet Mex 2020; 88 (06)

Combination of uric acid and serum albumin as predictive biomarkers of severe preeclampsia

Hidalgo-Carrera JA, Linder-Efter C, Chaya-Hajj M, Von der Meden-Alarcón JW, Rodríguez-Lane R, Ramírez-Valencia MF
Full text How to cite this article

Language: Spanish
References: 19
Page: 357-362
PDF size: 239.99 Kb.


Key words:

Serum uric acid, Severe preeclampsia, Uric acid, Albumin, Hypoalbuminemia, Biomarkers.

ABSTRACT

Objective: To determine if the combination of serum uric acid and albumin levels from weeks 20 to 24 of gestation are predictors of severe preeclampsia.
Materials and Methods: A retrospective and observational case-control study was carried out, in which the levels of uric acid and albumin taken during the 20th to 24th week were analyzed and compared with patients who developed severe preeclampsia. The data was collected in Microsoft Excel for Mac version 2019 and the statistical analysis was performed in SPSS for Mac version 25.
Results: 122 cases and 199 controls were obtained. Elevation of uric acid levels (≥4.9 mg/dL) and hypoalbuminemia (‹3.5 mg/dL) obtained statistical significance for severe preeclampsia compared to the control group (p ‹0.001). The logistic regression model obtained an OR to predict severe preeclampsia of 6.736 (CI95% 2.5-17.7) for uric acid elevation and OR of 11.337 (CI95% 4.5-28.3) for hypoalbuminemia (p ‹0.001).
Conclusion: In this study the statistically significant relationship was observed between the increase in uric acid levels and serum hypoalbuminemia from weeks 20 to 24 as predictive biomarkers of severe preeclampsia. However, more studies should be carried out to verify its clinical utility.


REFERENCES

  1. Rezk M, et al. First versus second trimester mean platelet volume and uric acid for prediction of preeclampsia in women at moderate and low risk. Hypertension in pregnancy 2018; 37 (3). https://doi.org/10.1080/10641955.2 018.1483508

  2. Soeters P, et al. Hypoalbuminemia: Pathogenesis and Clinical Significance. JPEN J Parenter Enteral Nutr 2019; 43 (2): 181-93. https://doi.org/10.1002/jpen.1451

  3. Chen H, et al. Association of hypoproteinemia in preeclampsia with maternal and perinatal outcomes: A retrospective analysis of high-risk women. J Res Med Sci 2016; 21: 98. 10.4103/1735-1995.193170

  4. Gojnic M, et al. Plasma albumin level as an indicator of severity of preeclampsia. Clin Exp Obstet Gynecol. 2004; 31 (3): 209-10. https://www.ncbi.nlm.nih.gov/ pubmed/15491066

  5. Pasyar S, et al. Investigating the diagnostic capacity of uric acid in the occurrence of preeclampsia. Pregnancy Hypertension. 2020; 19: 106-11. https://doi.org/10.1016/j. preghy.2019.12.010

  6. Gómez LM. Actualización en la fisiopatología de la preeclampsia. Rev Peru Ginecol Obstet 2014; 60 (4): 321-31. http://www.scielo.org.pe/scielo.php?script=sci_arttext& pid=S2304-51322014000400008

  7. Benoit J, et al. Preeclampsia: should plasma albumin level be a criterion for severity? J Obstet Gynaecol Can. 2011; 33 (9) (21923989):922-6. https://doi.org/10.1016/S1701- 2163(16)35017-4

  8. Yescas-Osorio I, et al. Correlación de la concentración sérica de ácido úrico en pacientes con preeclampsia severa en la unidad de cuidados intensivos. Ginecol Obstet Mex. 2017; 85 (6): 347-354. http://www.scielo.org.mx/pdf/gom/ v85n6/0300-9041-gom-85-06-347.pdf

  9. Ghazali B, et al. Study of the clinical significance of serum albumin level in preeclampsia and in the detection of its severity. American Journal of BioMedicine. 2014;2 (8): 899-902. https://ajbm.net/significance-of-serum-albuminlevel- in-preeclampsia/

  10. Seong W, et al. Clinical significance of serum albumin level in pregnancy-related hypertension. J Obstet Gynaecol Res. 2010; 36 (6). https://doi.org/10.1111/j.1447- 0756.2010.01296.x

  11. Bainbridge S, et al. Uric acid as a pathogenic factor in pre-eclampsia. Placenta 2008; 29 (Suppl A): S67-72. doi: 10.1016/j.placenta.2007.11.001

  12. Álvarez V, et al. El ácido úrico como factor predictor de la preeclampsia. Revista Cubana de Obstetricia y Ginecología 2018; 44 (2). http://scielo.sld.cu/pdf/gin/v44n2/ gin07218.pdf

  13. Devgun M, et al. Importance of diurnal variations on clinical value and interpretation of serum urate measurements. J Clin Pathol. 1992; 45 (2): 110-13. doi: 10.1136/jcp.45.2.110

  14. Zhao X, et al. Uric acid levels in gestational hypertensive women predict preeclampsia and outcome of small-forgestational- age infants. J Matern Fetal Neonatal Med. 2019: 1-7. doi: 10.1080/14767058.2019.1671339

  15. Chescheir N. Serum uric acid measurement in women with hypertensive disorders of pregnancy. Obstetrics & Gynecology. 2019; 134 (3): 636-38. doi: 10.1097/ AOG.0000000000003408.

  16. Ryu A, et al. Predictive value of serum uric acid levels for adverse perinatal outcomes in preeclampsia. Medicine. 2019; 98 (18): e15462. doi: 10.1097/MD.0000000000015462.

  17. Cohen S, et al. Effect of fetal number on maternal serum uric acid concentration. Am J Perinatol 2002; 19: 291-6. https://www.thieme-connect.com/products/ejournals/ html/10.1055/s-2002-34470

  18. Le T, et al. Maternal serum uric acid concentration and pregnancy outcomes in women with pre-eclampsia/eclampsia. Int J Gynaecol Obstet. 2018; 144 (1): 21-26. doi: 10.1002/ijgo.12697.

  19. Duan Z, et al. Alterations of several serum parameters are associated with preeclampsia and may be potential markers for the assessment of PE severity. Disease Markers. 2020; 2020: 1-7. doi: 10.1155/2020/7815214




2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

Ginecol Obstet Mex. 2020;88